Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.

Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.

Item
http://www.wikidata.org/entity/Q34860000
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapyIncreases in serum CYFRA21-1 concentration during successful treatment with crizotinib.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.Club cell protein 16 and cytokeratin fragment 21-1 as early predictors of pulmonary complications in polytraumatized patients with severe chest trauma.EMT influences the expression of CK19 in pleural effusion-derived lung cancer cells and their invasion and metastasis.Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer.History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects.Evaluation of VEGF-C and tumor markers in bronchoalveolar lavage fluid for lung cancer diagnosis.Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.Screening and Biosensor-Based Approaches for Lung Cancer Detection.Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.Relationship between pretreatment levels of serum Cyfra 21.1, CEA and PET metabolic parameters in NSCLC.Postoperative dynamic changes in the concentration of CK19-2G2 in lung cancer patients and the clinical value of this marker.
P2860

Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.

Item
http://www.wikidata.org/entity/Q34860000
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@ast
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@en
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@nl
type
label
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@ast
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@en
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@nl
prefLabel
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@ast
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@en
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Prognostic impact of serum CYF ...... cinoma: a retrospective study.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932